Exploring the connection between brain tumor patients and their pets

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on understanding the concerns and needs of patients diagnosed with brain tumors who own pets. It aims to analyze how the progressive neurological deficits and life-threatening prognosis of these patients impact their ability to care for their pets. By utilizing the Lexington Attachment to Pets Scale, the study seeks to assess the emotional burden on patients and the well-being of their pets during challenging times. The findings could inform better support systems for both patients and their pets.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with a brain tumor.
* Patients who own at least one pet.

Exclusion Criteria:

* Patients who decline to participate in the study.
* Patients unable to complete the questionnaire.

Where it's running

• CHU Saint Etienne
  Saint-Etienne, France Recruiting

Study contacts

• Principal investigator: Carole Ramirez, Md — CHU de SAINT-ETIENNE
• Study coordinator: Carole Ramirez, Md
• Email: carole.ramirez@chu-st-etienne.fr
• Phone: (0)477829326

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Connectome-guided network planning for brain tumor surgery in eloquent areas

  This study tests whether using patient-specific brain network maps from diffusion MRI can help surgeons plan and guide brain tumor removal in eloquent areas.

  Recruiting ARNAS Civico Di Cristina Benfratelli Hospital · Palermo, PA · NCT07717827

• Combining Gamma Knife and Linac radiosurgery for large brain tumors and metastases

  This will test whether using both Gamma Knife and Linac stereotactic radiosurgery in adults with large brain tumors or brain metastases can improve tumor control and reduce side effects.

  Recruiting Phase 2 Sunnybrook Health Sciences Centre · Toronto, Ontario · NCT07162246

• Vision-language AI to diagnose brain diseases from imaging and clinical data

  This project will test a new AI that reads scans, pathology, genomics, and clinical records to help diagnose a wide range of brain diseases for patients with tumors, vascular problems, or neurodegeneration.

  Recruiting Xiangya Hospital of Central South University · Changsha, Hunan · NCT07126821

• Pharmacoscopy-guided treatment for refractory brain tumors

  This trial tests whether personalized drug testing on a patient’s tumor cells can guide treatment choices for adults with hard-to-treat brain cancers like glioblastoma.

  Recruiting Phase 2 University of Zurich · Basel, Basel-Landschaft and 2 other locations · NCT06804655

• HOPE: Clinical, Pathology, and Imaging Project for Brain Tumors

  This project collects clinical records, MRI scans, and pathology data from people with glioma and other primary brain tumors to build large databases for improving diagnosis and care.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT05859659

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.